THE COST-EFFECTIVENESS OF RIVAROXABAN COMPARED TO ENOXAPARIN PLUS ADJUSTED-DOSE WARFARIN FOR THE TREATMENT OF DEEP VENOUS THROMBOSIS (DVT) IN TURKEY

Autor:	Birsen Ince, G. Ongen, M.O. Ozel, Zeki Öngen, Muzaffer Demir, C. Deger, E. Parali, B. Marmarali, F. Sumer, Z.S. Yilmaz, Hakan Kültürsay, K. Bozkurt, E. Tuna, Oktay Özdemir
Přispěvatelé:	Ege Üniversitesi
Jazyk:	angličtina
Rok vydání:	2013
Předmět:	Venous thrombosis Rivaroxaban business.industry Cost effectiveness Health Policy Anesthesia Public Health Environmental and Occupational Health medicine Dose warfarin medicine.disease business medicine.drug
Popis:	WOS: 000318916402451
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a0479b1a81fb0bd8e7705970983d9ca https://hdl.handle.net/11454/47569 Zobrazit plný text záznamu